2013年美国心力衰竭管理指南(心衰指南)-英文

Yancy, CW et al.

2013 ACCF/AHA Heart Failure Guideline This document was approved for publication by the governing bodies of the ACCF and AHA and

endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and Heart Rhythm Society.

Table 1. Applying Classification of Recommendation and Level of Evidence

A recommendation with Level of Evidence B or C does not imply that the recommendation is weak. Many important clinical questions addressed in the guidelines do not lend themselves to clinical trials. Although randomized trials are unavailable, there may be a very clear clinical consensus that a particular test or therapy is useful or effective.

*Data available from clinical trials or registries about the usefulness/efficacy in different subpopulations, such as sex, age, history of diabetes, history of prior myocardial infarction, history of heart failure, and prior aspirin use.

For comparative effectiveness recommendations (Class I and IIa; Level of Evidence A and B only), studies that support the use of comparator verbs should involve direct comparisons of the treatments or strategies being evaluated.

1.4. Scope of This Guideline With Reference to Other Relevant Guidelines or Statements